Jaguar Health JAGX
NASDAQ JAGX
$2.63 -0.19 (-6.74%)
At close: Oct 20, 2026 · 4:00 PM EDT

Jaguar Health (JAGX) Convertible Debt (2017 - 2018)

Updated

Jaguar Health (JAGX) reported Convertible Debt of $10.66 million for Q3 2018, down 4.5% from $11.16 million a year earlier.

Analysis

Jaguar Health (JAGX) Convertible Debt (2017 - 2018) Analysis & Trends

At the end of FY2017, Jaguar Health posted Convertible Debt of $10.98 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Jaguar Health 143,213.35 -15.42 Mn 194,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 10.66 Mn
Dec 31, 2017 10.98 Mn
Sep 30, 2017 11.16 Mn
API Access

Jaguar Health Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=JAGX&period=max&api_key=YOUR_API_KEY